ALEXANDRIA, Va.-Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, is pleased to announce that its Healthcare Real … Continued
ALEXANDRIA, Va. — Oxford Finance LLC (“Oxford”), a leading specialty finance firm focused on healthcare services and life sciences companies worldwide, today announced the closing of a $115 million senior … Continued
SOUTHLAKE, Texas, Nov. 14, 2022 /PRNewswire/ — Renibus Therapeutics, Inc., (“Renibus”), a clinical-stage biotechnology company developing breakthrough products for cardiorenal diseases, today announced a $33 million bridge financing consisting of a $23 million SAFE (Simple Agreement … Continued
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, … Continued
ALEXANDRIA, Va. & HOWELL, N.J.–(BUSINESS WIRE)–Oxford Finance LLC (“Oxford”), a leading specialty finance firm providing senior debt to healthcare services and life sciences companies worldwide, today announced the closing of … Continued
Oxford’s Healthcare Real Estate Group closed over $347 million of transactions during Q2 & Q3 of 2022, bringing the total commitments YTD to over $636 million. Despite the uncertain economic … Continued
